[Boston, 18th June 2025] – The global neurorehabilitation devices market is projected to surge from USD 2.1 billion in 2023 to USD 14.3 billion by 2035, growing at a CAGR of 21.3%, according to Clearview Market Insights. This growth is driven by demand for stroke rehabilitation, trends in home-based care, and AI-powered personalized therapy.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-neurorehabilitation-devices-market/

Key Growth Catalysts

1. Stroke Epidemic:
• 15 million annual cases worldwide (2030 estimate); robotic gait trainers can reduce recovery time by 40%.
• BCIs enable paralyzed patients to communicate using brain signals (90% accuracy in trials).
2. Home Healthcare Boom:
• Neuroelectrics’ Starstim becomes the first FDA-cleared home-use tDCS device (2025).
• 50% of patients now opt for telerehab post-discharge.
3. Military/VA Adoption:
• Ekso Bionics’ exoskeletons deployed in 50+ VA hospitals (2025).

Competitive Intensity

• Hocoma (30% share): Dominates with Lokomat Pro, now improved with real-time AI analytics.
• MindMaze (startup): VR neurorehab games attract USD 200M in funding.

Regional Leaders

• North America (XX%): U.S. accounts for 60% of robotic device sales.
• Asia-Pacific (20%): Japan’s stroke rehab centers adopt hybrid exoskeletons.

Future Milestones

• 2026: First cloud-based rehab platform with FDA approval.
• 2028: BCIs enter mainstream for locked-in syndrome.
• 2030: 70% of rehab occurs at home via AI-guided devices.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369